Search filters

List of works by Michael Weller

2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size

scientific article published on 2 November 2011

2010: neuro-oncology is moving!

scientific article published on December 2010

68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?

scientific article published on 09 February 2016

<scp>AllergoOncology</scp>: Biomarkers and refined classification for research in the allergy and glioma nexus—A joint <scp>EAACI‐EANO</scp> position paper

scientific article published in 2024

A 63-year-old man with dementia, ataxia and VI nerve palsy

scientific article

A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Ris

scientific article published on 18 December 2016

A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis

scientific article published on April 1, 1993

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics

scientific article published on 21 February 2017

A comprehensive analysis of vascular complications in 3,889 glioma patients from the German Glioma Network

scientific article published on October 27, 2012

A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells

scientific article published on 09 December 2013

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

scientific article

A new look at the role of p53 in leukemia cell sensitivity to chemotherapy

scientific article published on 01 November 1997

A novel tool to analyze MRI recurrence patterns in glioblastoma

scientific article published on 31 July 2008

A series of patients with subpial hemorrhage: clinical manifestation, neuroradiological presentation and therapeutic implications

scientific article

A specific miRNA signature in the peripheral blood of glioblastoma patients

scientific article published on 17 June 2011

A tissue-based draft map of the murine MHC class I immunopeptidome

article by Heiko Schuster et al published 7 August 2018 in Scientific Data

ACNU-based chemotherapy for recurrent glioma in the temozolomide era.

scientific article

APO010, a synthetic hexameric CD95 ligand, induces death of human glioblastoma stem-like cells

scientific article published on September 2013

APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo

scientific article

APO2 ligand: a novel lethal weapon against malignant glioma?

scientific article published on May 1, 1998

ATPS-73BIOLOGICAL ACTIVITY OF TUMOR-TREATING FIELDS (TTFIELDS) IN GLIOMA MODELS IN A PRECLINICAL SETTING.

scientific article published on 9 November 2015

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma

scientific article published on 27 November 2014

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis

scientific article

Abstract 4736: N-myc downstream regulated gene 1: A novel mediator of hypoxia-driven chemoresistance in glioblastoma

article

Abstract 4: Antitumor activity of DLX1008, a single chain antibody fragment binding to VEGF-A, in in vivo preclinical models of Kaposi sarcoma and glioblastoma

Acetazolamide-responsive migraine in CADASIL

scientific article published on 01 May 1998

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

scientific article (publication date: 16 June 2013)

Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes

scientific article published in November 2003

Addition of lomustine for bevacizumab-refractory recurrent glioblastoma

scientific article

Adenoviral (full-length) Apo2L/TRAIL gene transfer is an ineffective treatment strategy for malignant glioma

scientific article published on January 2003

Adenoviral natural born killer gene therapy for malignant glioma

scientific article published in September 2003

Adjuvant therapy

scientific article published on January 2009

Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities

scientific article published on 19 June 2015

Advances in the molecular genetics of gliomas - implications for classification and therapy

scientific article published on 29 December 2016

Aerosol and cloud effects on solar brightening and the recent rapid warming

article

Age-associated and therapy-induced alterations in the cellular microenvironment of experimental gliomas

scientific article published on 3 August 2017

Altered intraoperative cerebrovascular reactivity in brain areas of high-grade glioma recurrence

scientific article published on 8 March 2016

Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas

scientific article published on 17 November 2015

An MRI view of a ruptured dermoid cyst

scientific article published in January 2006

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

scientific article

An engineered 4-1BBL fusion protein with "activity on demand"

scientific article published on 25 November 2020

Analysis of the protein pattern in physiologic and pathologic vitreous bodies by electrophoresis and immunologic identification

scientific article published on January 1, 1991

Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations

scientific article published on 21 March 2018

Anaplastic oligodendroglioma: a new treatment paradigm and current controversies

scientific article

Angiogenesis in glioblastoma: just another moving target?

scientific article published on 30 March 2010

Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825.

scientific article published in August 2013

Angiogenesis inhibition: quo vadis?

scientific article published on November 1, 2012

Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy

scientific article

Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.

scientific article published on 4 May 2009

Anterior opercular cortex lesions cause dissociated lower cranial nerve palsies and anarthria but no aphasia: Foix-Chavany-Marie syndrome and ?automatic voluntary dissociation? revisited

scientific article published on January 1, 1993

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

scientific article published on September 1, 1994

Anti-phospholipid antibodies and cerebral ischemia

scientific article published on 01 June 1992

Antiangiogenic therapy for glioblastoma: current status and future prospects

scientific article

Antiangiogenic treatment for multiple CNS hemangioblastomas

scientific article published on 3 July 2012

Anticoagulation for radiation-induced neurotoxicity revisited

scientific article published on 22 August 2008

Anticonvulsant drugs fail to modulate chemotherapy-induced cytotoxicity and growth inhibition of human malignant glioma cells

scientific article published on May 1, 1998

Antidepressant drug use in glioblastoma patients: an epidemiological view

scientific article published on 25 April 2020

Antitumor Activity of DLX1008, an Anti-VEGFA Antibody Fragment with Low Picomolar Affinity, in Human Glioma Models.

scientific article

Apoptosis in Proliferative Vitreoretinal Disorders: Possible Involvement of TGF-β-induced RPE cell Apoptosis

scientific article published on September 1, 1997

Apoptosis in gliomas, and its role in their current and future treatment

scientific article

Apoptosis in gliomas: molecular mechanisms and therapeutic implications

scientific article

Appropriate end-points for right results in the age of antiangiogenic agents: future options for phase II trials in patients with recurrent glioblastoma

scientific article

Approval of new drugs for glioblastoma.

scientific article published in December 2009

Are CSF or serum ganglioside antibodies related to peripheral nerve demyelination in neuroborreliosis, Guillain-Barré syndrome, or chronic inflammatory demyelinating polyradiculoneuropathy?

scientific article published on January 1, 1992

Are we ready for a randomized trial of valproic acid in newly diagnosed glioblastoma?

scientific article published on July 1, 2013

Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma?

scientific article published on April 2011

Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial

scientific article

Assessing response to chemotherapy in malignant glioma: The role of steroids

scientific article published on April 1, 1998

Assessing the MGMT status in glioblastoma: one step forward, two steps back?

scientific article published in March 2013

Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy

scientific article published in May 2014

Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo

scientific article published on 23 March 2016

Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma

scientific article published on 5 May 2017

Autoimmune myasthenia gravis after sternal fracture

scientific article published on 20 January 2012

Automatic-voluntary dissociation: an unusual facial paresis in a patient with probable multiple sclerosis

scientific article published on January 1, 1992

BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study

scientific article published on February 18, 1998

BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells

scientific article published on January 2002

BCL-2-induced glioma cell invasiveness depends on furin-like proteases

scientific article

BI-32RISK FACTOR ANALYSIS FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA WHO DID NOT RECEIVE SALVAGE THERAPY.

scientific article published in November 2014

Bcl-2, Bax and Bcl-x expression in neuronal apoptosis: a study of mutant weaver and lurcher mice

scientific article published on September 1, 1998

Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas

scientific article published on 22 November 2012

Bevacizumab and recurrent malignant gliomas: a European perspective

scientific article

Bevacizumab does not increase the risk of remote relapse in malignant glioma.

scientific article

Bevacizumab--news from the fast lane?

scientific article published on 5 September 2008

Bevacizumab: Zankapfel der Glioblastomtherapie

scientific article published on April 2017

Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma

scientific article published on 4 April 2017

Biological activity of tumor-treating fields in preclinical glioma models

scientific article published on 20 April 2017

Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.

scientific article

Boswellic acid activity against glioblastoma stem-like cells

scientific article

Brain metastasis research: a late awakening

scientific article

CCNU overdose during PCV chemotherapy for anaplastic astrocytoma

scientific article published on April 1, 1998

CD 95 expression in traumatic proliferative vitreoretinopathy: a target for the induction of apoptosis

scientific article published on 01 November 1996

CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms

scientific article published on 25 March 2011

CD95 Ligand: Lethal Weapon Against Malignant Glioma?

scientific article published on April 1, 1998

CD95 ligand-induced apoptosis of human medulloblastoma cells

scientific article published on June 19, 1998

CD95-mediated apoptosis of human glioma cells: modulation by epidermal growth factor receptor activity

scientific article published in January 2002

CD95‐mediated apoptosis: no variation in cellular sensitivity during cell cycle progression

scientific article published on 01 August 1998

CHD7 promotes glioblastoma cell motility and invasiveness through transcriptional modulation of an invasion signature

article by Raquel A C Machado et al published 8 March 2019 in Scientific Reports

CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death

scientific article published on November 13, 2003

CS-35TGF-β INDUCES AND BMP SUPPRESSES VEGF RELEASE DEPENDING ON SMAD2/3 VERSUS SMAD1/5/8 SIGNALING IN GLIOBLASTOMA.

scientific article published in November 2014

CT‐only planning for Gamma Knife radiosurgery in the treatment of trigeminal neuralgia: Methodology and outcomes from a single institution

scientific article published on July 8, 2012

Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling

scientific article published on 01 January 2020

Cancer risk among patients with multiple sclerosis and their parents

scientific article

Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma

scientific article published on 24 October 2015

Cellular stimulation via CD95 involves activation of phospho-inositide-3-kinase

scientific article published on March 1, 1998

Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis

scientific article

Ceramide metabolism determines glioma cell resistance to chemotherapy

scientific article

Challenges in the diagnoses and treatment of CNS tumors

scientific article published on 20 September 2019

Changes in survival by combined radio-chemotherapy

scientific article published in January 2004

Changing paradigms--an update on the multidisciplinary management of malignant glioma

scientific article

Characterization of CD95 ligand (CD95L)-induced apoptosis in human tenon fibroblasts

scientific article published on July 2002

Characterization of daunorubicin-induced apoptosis in retinal pigment epithelial cells: modulation by CD95L.

scientific article

Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide

scientific article published on 14 October 2009

Chemosensitivity of human malignant glioma: modulation by p53 gene transfer

scientific article published on August 1, 1998

Chemotherapy for intracranial ependymoma in adults

scientific article

Chemotherapy for low-grade gliomas: when? how? how long?

scientific article published on October 2010

Chemotherapy primes malignant glioma cells for CD95 ligand-induced apoptosis up-stream of caspase 3 activation

scientific article published on July 3, 1998

Chemotherapy-induced cell death in primary cerebellar granule neurons but not in astrocytes: in vitro paradigm of differential neurotoxicity

scientific article published in December 2004

Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma

scientific article

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

scientific article

Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro

scientific article published on December 2009

Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression

scientific article

Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies

scientific article

Classification and management of anaplastic gliomas

scientific article published on December 2009

Clinical implications of molecular neuropathology and biomarkers for malignant glioma

scientific article published on June 2012

Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients

scientific article

Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials.

scientific article published on 18 April 2011

Clinical trials in neuro-oncology: one step forward, two steps back?

scientific article published in December 2011

Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'

scientific article published on 01 December 1992

Co-inhibition of epidermal growth factor receptor and type 1 insulin-like growth factor receptor synergistically sensitizes human malignant glioma cells to CD95L-induced apoptosis

scientific article published on August 2004

Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?

scientific article

Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatients

scientific article published on April 20, 2012

Complementary and alternative medicine use by glioma patients in Switzerland

scientific article published on 12 October 2018

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial

scientific article published on 27 January 2016

Computer-assisted quantification of motile and invasive capabilities of cancer cells

scientific article

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

scientific article (publication date: September 2015)

Contraceptive drugs mitigate experimental stroke-induced brain injury

scientific article published on 01 March 2019

Contractile elements in proliferative retinal diseases

scientific article published on 01 February 1992

Control of glioma cell migration and invasiveness by GDF-15

scientific article published on 04 January 2016

Copy number profiling across glioblastoma populations has implications for clinical trial design.

scientific article

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity

scientific article published on September 2008

Corrigendum: Computer-assisted quantification of motile and invasive capabilities of cancer cells.

scientific article published on 2 July 2018

Corticosteroid use in neuro-oncology: an update

scientific article published on 09 October 2014

Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.

scientific article

Current State of Immune-Based Therapies for Glioblastoma

scientific article published on January 2016

Current concepts and management of glioblastoma

scientific article published on July 2011

Current state of immunotherapy for glioblastoma.

scientific article

DIRECT CELL CONTACT BETWEEN BRAIN ENDOTHELIAL CELLS AND GLIOMA STEM CELLS PROMOTES ENDOTHELIAL CELL MIGRATION.

scientific article published in July 2014

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

scientific article published on 14 March 2017

DNA methylation-based classification of central nervous system tumours

scientific article published on 14 March 2018

Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L system

scientific article

Dedication: Andrew T. Parsa

scientific article published in November 2015

Defective p53 antiangiogenic signaling in glioblastoma

scientific article

Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia/reperfusion brain injury

scientific article published on 24 September 2012

Demonstration of mononuclear phagocytes in a human epiretinal membrane using a monoclonal anti-human macrophage antibody

scientific article published on January 1, 1988

Determining medical decision-making capacity in brain tumor patients: why and how?

scientific article published on 16 July 2020

Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?

scientific article published on September 24, 1998

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

scientific article published on February 2017

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

scientific article published on July 2015

Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe

scientific article published on 28 April 2017

Diagnostic value of fibronectin determination in cerebrospinal fluid

scientific article published on June 1, 1992

Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation

scientific article published in October 2013

Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma

scientific article published on 27 August 2014

Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients

scientific article

Diffuse gliomas exhibit whole brain impaired cerebrovascular reactivity

scientific article published on 3 October 2017

Diphenylhydantoin induces apoptotic cell death of cultured rat cerebellar granule neurons

scientific article published on August 1, 1995

Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells

scientific article published on 30 May 2016

Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells

scientific article published on 28 May 2012

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system

scientific article published on 24 October 2013

Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?

scientific article published on 8 February 2018

Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma

scientific article published on 19 January 2016

Does cilengitide deserve another chance?-Authors' reply

scientific article published on 24 November 2014

Drug-related problems and factors influencing acceptance of clinical pharmacologists` alerts in a large cohort of neurology inpatients

scientific article published on 9 July 2012

Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363.

scientific article

Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses.

scientific article

EANO guidelines for the diagnosis and treatment of ependymal tumors

scientific article published on 29 November 2017

EANO guidelines for the diagnosis and treatment of meningiomas

scientific article published on 30 August 2016

EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma

scientific article

EGR-1 is regulated by N-methyl-D-aspartate-receptor stimulation and associated with patient survival in human high grade astrocytomas

scientific article

EPID-16PATTERNS OF CARE AND OUTCOME IN GLIOBLASTOMA PATIENTS IN THE CANTON OF ZURICH: A POPULATION-BASED STUDY (2005-2009).

scientific article

ERGO: a pilot study of ketogenic diet in recurrent glioblastoma

scientific article

Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial

scientific article published on 22 April 2017

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial

scientific article published in December 2017

Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model

scientific article published on November 2004

Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma

scientific article published in August 2007

Efficacy of Surgery and Further Treatment of Progressive Glioblastoma

scientific article published on 19 March 2015

Electroconvulsive therapy in a geriatric patient with multiple bone fractures and generalized plasmocytoma

scientific article published on November 1, 1992

Electroconvulsive therapy in treatment of acute life threatening catatonia in toxic epidermal necrolysis (Lyell syndrome)

scientific article (publication date: May 1992)

Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.

scientific article

End-of-life caregivers' perception of medical and psychological support during the final weeks of glioma patients: a questionnaire-based survey

scientific article published on 28 June 2013

Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis

scientific article

Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL.

scientific article

Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.

scientific article

Epidermal growth factor receptor: a re-emerging target in glioblastoma

scientific article published on December 2012

Epilepsy meets cancer: when, why, and what to do about it?

scientific article published on September 2012

Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity

scientific article published on 7 January 2016

Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System).

scientific article published on 20 July 2011

Evolution of glioblastoma.

scientific article

Express and protect yourself: the potential role of HLA-G on muscle cells and in inflammatory myopathies

scientific article (publication date: November 2003)

Expression and functional activity of osteoprotegerin in human malignant gliomas

scientific article published on September 23, 2003

Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines

scientific article

Expression and upregulation of microtubule-associated protein 1B in cultured retinal pigment epithelial cells

scientific article published on 01 December 1997

Expression of integrins αvβ3 and αvβ5 and their ligands in primary and secondary central nervous system neoplasms

scientific article

Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis

scientific article published on November 2003

Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo

scientific article (publication date: December 2003)

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity

scientific article published on 25 August 2005

Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survival

scientific article published in May 2007

Federated learning enables big data for rare cancer boundary detection

GDF-15 contributes to proliferation and immune escape of malignant gliomas

scientific article published on 9 June 2010

Ganglioside antibodies: a lack of diagnostic specificity and clinical utility?

scientific article published on 01 October 1992

Gender issues from the perspective of health-care professionals in Neuro-oncology: an EANO and EORTC Brain Tumor Group survey

scientific article published on 10 January 2020

Gene-Tailored Treatments for Brain Disorders: Challenges and Opportunities

scientific article published on June 2016

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets

scientific article published on July 2002

Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population

scientific article published on 17 March 2010

Genetic variants of homocysteine metabolism and multiple sclerosis: a case-control study

scientific article

Genetic variants of methionine metabolism and X-ALD phenotype generation: results of a new study sample

scientific article

Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma.

scientific article

Geriatric neuro-oncology: from mythology to biology

scientific article published on December 2011

Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation

scientific article

Glioblastoma

scientific article published on January 2016

Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.

scientific article

Glioblastoma stem cells

scientific article published on January 21, 2011

Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway

scientific article

Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta

scientific article published on June 1, 2001

Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.

scientific article published on October 2008

Glioma tropism of lentivirally transduced hematopoietic progenitor cells.

scientific article published in June 2010

Glioma.

scientific article published on 16 July 2015

Gliomas – What I Have to Know in ten Questions

scientific article

Gliomatosis cerebri: molecular pathology and clinical course

scientific article published in October 2002

Gliomatosis cerebri: no evidence for a separate brain tumor entity

scientific article published on 22 October 2015

Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply

scientific article published in December 2017

HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells

scientific article

HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo

scientific article published on June 2005

Hide-and-seek in the brain: a role for HLA-G mediating immune privilege for glioma cells

scientific article published on October 2003

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

scientific article published on 20 October 2010

High-dose praziquantel therapy for cerebral sparganosis

scientific article

How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience

scientific article published in June 2005

How stemlike are sphere cultures from long-term cancer cell lines? Lessons from mouse glioma models

scientific article published on November 2014

How to define the opercular syndrome?

scientific article published on May 1, 1992

How we treat glioblastoma

scientific article published on 17 June 2019

Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins

scientific article (publication date: June 2003)

Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies

scientific article

Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia

scientific article published on August 1, 1992

Humoral immune response to p53 in malignant glioma

scientific article published on March 1, 1998

Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53

scientific article published on October 1, 1997

Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors

scientific article published in 2022

Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acid

scientific article

Hypoxia sensitizes human malignant glioma cells towards CD95L-induced cell death.

scientific article published on March 2005

INHIBITING INVASION AND STEMNESS IN GLIOBLASTOMA BY THYMOSIN BETA 4 GENE SILENCING: A POTENTIAL THERAPEUTIC TARGET?

scientific article

IT-28VACCINATION AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III IN GLIOBLASTOMA: THE RINDOPEPIMUT COMPASSIONATE USE EXPERIENCE.

scientific article published in November 2014

Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma

scientific article

Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer

scientific article published on 2 November 2017

Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma

scientific article published on 14 August 2017

Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor

scientific article published on October 1, 1992

Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide

scientific article published on 18 August 2009

Immediate postoperative radiotherapy or "watch and wait" in the management of adult low-grade glioma?

scientific article published in July 2004

Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo

scientific article

Immunocytokines are a promising immunotherapeutic approach against glioblastoma

scientific article published on 01 October 2020

Immunological abnormalities in the tears of multiple sclerosis patients

scientific article published on March 1, 1992

Immunological challenges for peptide-based immunotherapy in glioblastoma

scientific article

Immunological effects of chemotherapy and radiotherapy against brain tumors

scientific article published on 6 September 2016

Immunology of brain tumors

scientific article published on January 2012

Immunosuppressive mechanisms in glioblastoma

scientific article

Immunotherapy for glioblastoma: a long and winding road

scientific article published on April 2010

Immunotherapy for glioblastoma: concepts and challenges

scientific article published on 22 September 2015

Immunotherapy of Brain Cancer

scientific article published on 25 May 2016

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

scientific article

Important themes in Neuro-Oncology Practice: Rare brain tumors, radiotherapy and its side effects, and supportive and palliative care

scientific article published on 31 July 2020

Individualized targeted therapy for glioblastoma: fact or fiction?

scientific article published on January 2012

Induction of Nitric Oxide Synthase and Nitric Oxide‐Mediated Apoptosis in Neuronal PC12 Cells After Stimulation with Tumor Necrosis FActor‐α/Lipopolysaccharide

scientific article published on July 1, 1998

Influence of gangliosides on experimental allergic neuritis

scientific article published on 01 June 1992

Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model

scientific article published on 23 May 2007

Inhibition of epidermal growth factor receptor signaling protects human malignant glioma cells from hypoxia-induced cell death

scientific article published in March 2004

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma

scientific article published on 10 July 2014

Interferon-α enhances CD95L-induced apoptosis of human malignant glioma cells

scientific article published on July 1, 1998

Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells

scientific article published on 6 October 2015

Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity

scientific article published on 01 January 2020

Interferon-β induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells

scientific article published on 13 February 2014

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

scientific article

Interleukin-33 in human gliomas: Expression and prognostic significance

scientific article published on 25 May 2016

Intracranial metastatic esthesioneuroblastoma responsive to temozolomide

scientific article published in October 2004

Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial

scientific article published on 10 September 2011

Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy

scientific article published on 01 January 1998

Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast).

scientific article published in October 2003

Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.

scientific article published on 10 July 2006

Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.

scientific article

Is there a role for benzodiazepines in the management of lumbar disc prolapse with acute sciatica?

scientific article published in April 2010

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

scientific article published on 13 March 2012

Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomas

scientific article published on 03 February 2011

Iterative analysis of cerebrovascular reactivity dynamic response by temporal decomposition

scientific article published on 26 July 2017

JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment

scientific article published on 16 September 2013

Leptomeningeal metastasis: survival and prognostic factors in 155 patients

scientific article published in August 2004

Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells

scientific article published on 9 June 2005

Letter to the Editor: "The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline" [J Neurooncol 2014; 118:435-460].

scientific article published on 24 August 2014

Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma

scientific article

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications

Lomustine and Bevacizumab in Progressive Glioblastoma

scientific article published in November 2017

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide

scientific article published on July 2016

Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti-PD-1 treatment with nivolumab

scientific article published on 29 December 2016

Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations

scientific article

Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide

scientific article

Long-term survival with glioblastoma multiforme

scientific article

Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence

scientific article published on 7 April 2018

Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell components

scientific article published in October 2007

Low molecular weight heparin for deep vein thrombosis in glioma patients

scientific article

Low-grade primary central nervous system lymphoma in immunocompetent patients

scientific article published in March 2005

Lyell syndrome and lethal catatonia: a case for ECT

scientific article published on 01 August 1992

Lysosomal ceramide mediates gemcitabine-induced death of glioma cells

scientific article published on 10 September 2009

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

scientific article published on 5 February 2015

MGMT gene silencing and benefit from temozolomide in glioblastoma

scientific article

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

scientific article

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

scientific article published on 08 December 2009

MGMT testing--the challenges for biomarker-based glioma treatment

scientific article

MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model

scientific article published on January 2004

MNGO-20SOMATOSTATIN RECEPTOR-TARGETED RADIONUCLIDE THERAPY FOR PROGRESSIVE MENINGIOMA.

scientific article

MR Imaging of Neoplastic Central Nervous System Lesions: Review and Recommendations for Current Practice

scientific article published on October 20, 2011

Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression

scientific article

Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.

scientific article published on June 2008

Malignant astrocytoma in elderly patients: where do we stand?

scientific article published on December 2013

Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective

scientific article published on 17 April 2013

Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1.

scientific article published on April 2007

Malignant optic glioma - the spectrum of disease in a case series

scientific article published on 26 May 2015

Management of Elderly Patients with Glioblastoma

scientific article published on April 2017

Management of diffusely infiltrating glioma in the elderly

scientific article published on 22 September 2015

Management of neoplastic meningitis

scientific article published on June 2015

Maximal surgical tumour load reduction in immune-checkpoint inhibitor naïve patients with melanoma brain metastases correlates with prolonged survival

scientific article published in 2022

Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients

scientific article published on 07 June 2020

Mechanisms of apoptosis in central nervous system tumors: application to theory

scientific article

Mechanisms of chemoresistance to alkylating agents in malignant glioma

scientific article published on May 2008

Mechanisms of resistance of human glioma cells to Apo2 ligand/TNF-related apoptosis-inducing ligand

scientific article

Meeting Update-World Federation of Neuro-Oncology Societies (WFNOS) Meeting 2017.

scientific article published in October 2017

Methylation of the p73 gene in gliomas

scientific article published on 3 July 2002

MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM.

scientific article

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape

scientific article

Microglia: a novel treatment target in gliomas

scientific article published in August 2012

Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas.

scientific article published on March 2005

Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells

scientific article

Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition

scientific article

Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis

scientific article

Modulation of neuronal activity by the endogenous pentapeptide QYNAD.

scientific article published in November 2003

Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.

scientific article

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

scientific article published on 18 March 2015

Molecular diagnostics of gliomas: the clinical perspective

scientific article published on 23 September 2010

Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.

scientific article published on 24 August 2017

Molecular markers in low-grade gliomas: predictive or prognostic?

scientific article

Molecular neuro-oncology in clinical practice: a new horizon

scientific article published on August 2013

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

scientific article published on 5 October 2009

Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis

scientific article published on February 2017

Monitoring the glioma tropism of bone marrow-derived progenitor cells by 2-photon laser scanning microscopy and positron emission tomography

scientific article

Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas

scientific journal article

Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

scientific article

Mononuclear Phagocytes in Proliferative Vitreoretinopathy (PVR). A Specific Role of Microglial Cells in Non-Traumatic Disease?

scientific article published on October 1, 1991

More on the immune privilege of glioblastoma

scientific article published on May 1, 2012

Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1).

scientific article

Movement disorders reveal Creutzfeldt-Jakob disease

scientific article published in April 2009

Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).

scientific article published on 21 August 2017

Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery

scientific article

Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies

scientific article published in May 2003

Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells

scientific article published on 9 November 2016

NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP.

scientific article

NKG2D-based CAR-T cells and radiotherapy exert synergistic efficacy in glioblastoma

scientific article published on 8 December 2017

NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report

scientific article

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

scientific article published on 9 November 2009

NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri

scientific article published on 27 June 2011

Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma

scientific article

Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study

scientific article published in September 2002

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma

scientific article

Neuro-oncology in 2013: improving outcome in newly diagnosed malignant glioma

scientific article published on 14 January 2014

Neuro-oncology, a decade of temozolomide and beyond

scientific article

Neurocognitive function: an emerging surrogate endpoint for neuro-oncology trials

scientific article published on June 1, 2011

Neurological symptoms in patients with biopsy proven celiac disease

scientific article published in December 2009

Neurology--the next 10 years

scientific article

New (alternative) temozolomide regimens for the treatment of glioma

scientific article published on 04 September 2008

New aspects of immunotherapy of leptomeningeal metastasis

scientific article published on June 1, 1998

New insights into acquired temozolomide resistance in glioblastoma?

scientific article published in December 2015

Next generation neuro-oncology

scientific article published on 12 April 2018

Niacinamide blocks 3-acetylpyridine toxicity of cerebellar granule cells in vitro

scientific article published on October 23, 1992

Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial

scientific article published on 28 July 2020

Novel TIE-2 inhibitor BAY-826 displays in vivo efficacy in experimental syngeneic murine glioma models

scientific article published on 27 October 2016

Novel cases of amyotrophic lateral sclerosis after treatment of cerebral arteriovenous malformationss

scientific article

Novel diagnostic and therapeutic approaches to malignant glioma

scientific article published on May 24, 2011

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas

scientific article published on 23 April 2018

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

scientific article published on 9 January 2006

Optimal management of elderly patients with glioblastoma

scientific article published on 19 June 2012

Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma

scientific article published on 13 June 2016

Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial

scientific article published on 15 August 2012

Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy

scientific article

P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells.

scientific article published on October 2003

PIK3CA alterations in primary (de novo) and secondary glioblastomas.

scientific article published on 18 January 2007

PTEN methylation and expression in glioblastomas

scientific article published on 2 August 2003

Paraneoplastic Necrotizing Myopathy with a Mild Inflammatory Component: A Case Report and Review of the Literature

scientific article published on 08 April 2010

Paranoid psychosis, epidermoid tumor, and epilepsy: "symptomatic" psychosis or coincidence?

scientific article published on July 1, 1992

Pathogenesis and management of primary CNS lymphoma

scientific article published on May 2012

Pathophysiology and therapy of malignant neuroleptic syndrome

scientific article published on 01 November 1992

Pathway inhibition: emerging molecular targets for treating glioblastoma

scientific article

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

scientific article

Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidence

scientific article

Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice

scientific article

Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives

scientific article published on 7 April 2016

Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long?

scientific article

Phase 2 trial design in neuro-oncology revisited: a report from the RANO group

scientific article published on May 2012

Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma

scientific article

Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.

scientific article published in September 2006

Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma

scientific article

Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer

scientific article

Pirfenidone inhibits TGF-beta expression in malignant glioma cells

scientific article published on 10 January 2007

Plasminogen in proliferative vitreoretinal disorders

scientific article published on July 1, 1997

Postpartum psychosis and mastitis: a new indication for clozapine?

scientific article published on 01 December 1991

Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression

scientific article published on 01 September 1998

Potentiation of Treosulfan Toxicity by the Glutathione-Depleting Agent Buthionine Sulfoximine in Human Malignant Glioma Cells

scientific article published on February 1, 1998

Predicting outcome of epilepsy after meningioma resection

scientific article published on 18 December 2015

Predicting response to cancer chemotherapy: the role of p53

scientific article published on June 1, 1998

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly

scientific article published on 11 January 2012

Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial

scientific article published on 15 January 2012

Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients

scientific article

Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status

scientific article published on 20 October 2009

Primary central nervous system lymphoma in the elderly

scientific article published on 7 July 2014

Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients

scientific article published on April 2005

Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?

scientific article published on 18 July 2014

Prime time for molecular marker diagnostics in neuro-oncology

scientific article published in December 2012

Procarbazine and CCNU as initial treatment in gliomatosis cerebri

scientific article published on 8 October 2008

Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time.

scientific article published on 21 March 2018

Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma

scientific article published on 26 March 2015

Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial

scientific article

Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial

scientific article published on March 5, 2012

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

scientific article published on 25 September 2013

Prognostic relevance of miRNA-155 methylation in anaplastic glioma

scientific article published on 18 November 2016

Prognostic role of Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified primary and recurrent glioblastomas

scientific article published on 29 August 2017

Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma

scientific article (publication date: 2012)

Program director and chief resident perspectives on the educational environment of US radiation oncology programs

scientific article

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

scientific article published on 29 October 2014

Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?

scientific article published on 2 July 2012

Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological disease

scientific article

Proliferative vitreoretinopathy. Activation of the complement system

scientific article published on 01 February 1992

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern

scientific article

Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.

scientific article

Proposed Response Assessment and Endpoints for Meningioma Clinical Trials: Report from the Response Assessment in Neuro-Oncology (RANO) Working Group

scientific article published on 01 January 2019

Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1.

scientific article

Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target

scientific article published on June 2014

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

scientific article

Radicular and nonradicular back pain in Parkinson's disease: a controlled study

scientific article published in April 2007

Radiochemotherapy for brain metastasis: how to define a role for temozolomide

scientific article published on 27 June 2007

Radiochemotherapy of malignant glioma in adults. Clinical experiences

scientific article

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

scientific article (publication date: 10 March 2005)

Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma

scientific article

Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis

scientific article

Rechallenge with temozolomide in patients with recurrent gliomas

scientific article published on 25 February 2009

Reciprocal modulation of Aβ42 aggregation by copper and homocysteine

scientific article published on 8 September 2014

Recurrent gastrointestinal tract bleeding secondary to jejunal gastric heterotopia

scientific article

Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach

scientific article published on 21 May 2013

Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression

scientific article published on April 2006

Relapse of primary CNS lymphoma after more than 10 years in complete remission

scientific article published on 20 May 2005

Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors

scientific article published on 13 May 2006

Reply to F. Felix et al and M.F. Fay et al.

scientific article published on 13 June 2016

Reply to glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.

scientific article

Reply: Corticosteroids compromise survival in glioblastoma in part through their elevation of blood glucose levels

scientific article published on 21 December 2016

Response Assessment of Meningioma: 1D, 2D and Volumetric Criteria for Treatment Response and Tumor Progression

scientific article published on 01 February 2019

RetroviralBAX gene transfer fails to sensitize malignant glioma cells to CD95L-induced apoptosis and cancer chemotherapy

scientific article published on August 12, 1998

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

scientific article published on 22 August 2017

Role of TGF-? in oncogenesis

S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease

scientific article published on 3 June 2010

SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo

scientific article published on 13 October 2009

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo

scientific article

Sex-specific aspects of epidemiology, molecular genetics and outcome: primary brain tumours

scientific article published on 01 November 2020

Shaping the glioma immune microenvironment through tryptophan metabolism

scientific article

Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?

scientific article published on September 2010

Signaling from cAMP/PKA to MAPK and synaptic plasticity

scientific article

Similar protective effects of BQ-123 and erythropoietin on survival of neural cells and generation of neurons upon hypoxic injury

scientific article published on November 2005

Single-institution retrospective series of gamma knife radiosurgery in the treatment of multiple sclerosis-related trigeminal neuralgia: factors that predict efficacy

scientific article published on 8 November 2013

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

scientific article

Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma

scientific article

Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake

scientific article published on 21 April 2016

Specific intensity imaging for glioblastoma and neural cell cultures with 5-aminolevulinic acid-derived protoporphyrin IX.

scientific article published in January 2005

Standards of care for treatment of recurrent glioblastoma--are we there yet?

scientific article published on 7 November 2012

Stem cell-mediated gene therapies for malignant gliomas: a promising targeted therapeutic approach?

scientific article published on June 2011

Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literature

scientific article published on June 2006

Steroids in neurooncology: actions, indications, side-effects

scientific article published on December 2010

Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism

scientific article published on 11 April 2022

Structures of neurooncological science and care

scientific article published on 01 August 2010

Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo

scientific article

Supraagonistic, bispecific single-chain antibody purified from the serum of cloned, transgenic cows induces T-cell-mediated killing of glioblastoma cells in vitro and in vivo.

scientific article published in December 2005

Surgery for primary CNS lymphoma? Challenging a paradigm

scientific article

Synergistic antiglioma activity of radiotherapy and enzastaurin

scientific article published in February 2007

Synergy of CD95 ligand and teniposide: No role of cleavable complex formation and enhanced CD95 expression

scientific article published on January 12, 1998

Synthesis of cytochrome c oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell death

scientific article published on November 28, 2011

TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells

scientific article published on 3 August 2006

TP53 promoter methylation in human gliomas

scientific article published on 16 July 2005

Targeting apoptosis pathways in glioblastoma

scientific article published on 26 January 2011

Targeting integrins in malignant glioma

scientific article published on 04 September 2010

Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells

scientific article published in September 2017

Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest

scientific article published on January 1, 1998

Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05).

scientific article

Temozolomide and MGMT forever?

scientific article published on March 2010

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

scientific article

Temozolomide: a milestone in the pharmacotherapy of brain tumors

scientific article

The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis

scientific article published on 01 March 2022

The Role of Molecular Diagnostics in the Management of Patients with Gliomas

scientific article

The age of Karl Ludwig Kahlbaum

scientific article published on January 15, 1992

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

scientific article published on March 1, 1995

The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010.

scientific article published on 7 January 2013

The effect of MTHFR c.677C>T on plasma homocysteine levels depends on health, age and smoking

scientific article published in December 2009

The effects of basic fibroblast growth factor on bovine retinal pigment epithelium in vitro

scientific article published on 01 January 1992

The legend of cytomegalovirus and glioblastoma lives on.

scientific article published on 4 December 2013

The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma

scientific article published on 28 September 2021

The management of lomustine overdose in malignant glioma patients

scientific article

The network of immunosuppressive pathways in glioblastoma

scientific article published on 22 December 2016

The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy

scientific article published on January 2003

The role of caspases 9 and 9-short (9S) in death ligand- and drug-induced apoptosis in human astrocytoma cells

scientific article published in October 2002

The role of integrins in glioma biology and anti-glioma therapies

scientific article published on January 2011

The significance of vitronectin in proliferative diabetic retinopathy

scientific article published on 01 August 1994

The time of maximum post-ischemic hyperperfusion indicates infarct growth following transient experimental ischemia

scientific article

The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines

scientific article

Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.

scientific article published on October 2006

Therapeutic options in recurrent glioblastoma--An update

scientific article published on 21 January 2016

Therapy for Secondary CNS Involvement in Malignant Lymphomas: No Standard Yet!

scientific article published on 21 March 2016

Thrombospondin: a new attachment protein in preretinal traction membranes

scientific article published on January 1, 1992

Thymosin β 4 gene silencing decreases stemness and invasiveness in glioblastoma

scientific article published on 18 December 2013

Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.

scientific article published in April 2009

Topoisomerase-I inhibitors for human malignant glioma: Differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and β-lapachone

scientific article published on November 27, 1997

Trabedersen to target transforming growth factor-beta: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142).

scientific article published on May 2011

Transcriptional control of O6 -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma.

scientific article

Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma

scientific article

Transforming growth factor-β pathway activity in glioblastoma

scientific article published on March 2015

Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis

scientific article published on March 15, 1992

Tumor-associated edema in brain cancer patients: pathogenesis and management

scientific article published on 23 October 2013

Tumour necrosis factor-alpha in malignant melanomatous meningitis

scientific article published on January 1, 1992

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

scientific article published on 25 June 2009

UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma

scientific article published in February 2005

Unilateral Thalamic Edema in Internal Cerebral Venous Thrombosis: Is it Mostly Left?

scientific article published on January 1, 2001

Unusual presentation of central nervous system metastases: mechanisms of spread and radiological findings

scientific article

VEGF-dependent induction of CD62E on endothelial cells mediates glioma tropism of adult haematopoietic progenitor cells

scientific article

Vaccine-based immunotherapeutic approaches to gliomas and beyond

scientific article published on 12 May 2017

Vertebral artery dissection presenting with ispilateral acute C5 and C6 sensorimotor radiculopathy: A case report

scientific article published on 3 September 2008

Very late relapses in glioblastoma long-term survivors

scientific article published on 12 May 2009

Vitronectin and fibronectin receptors in proliferative retinal diseases

scientific article published on 01 January 1990

Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy

scientific article published on March 1, 1991

Vitronectin: mediator of cell adhesion in proliferative vitreoretinopathy?

scientific article published on January 1, 1990

WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?

scientific article published on 31 May 2007

Where does O6 -methylguanine DNA methyltransferase promoter methylation assessment place temozolomide in the future standards of care for glioblastoma?

scientific article published on 30 January 2018

Will integrin inhibitors have proangiogenic effects in the clinic?

scientific article published in July 2009

cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification

scientific article published on 20 December 2016

mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy

scientific article

αv-Integrin isoform expression in primary human tumors and brain metastases

scientific article published on 10 June 2013